[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Xilin Sun\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100586155","study-on-c-met-targeted-petct-imaging-in-nsclc-100586155",false,"NCT06911697","Study on c-Met Targeted PET\u002FCT Imaging in NSCLC","In Vivo Detection of c-Met Activation Status by Specific PET\u002FCT Imaging Based on 18F Labeled Small Molecule TKI","Inclusion Criteria:\n\n1. Age range 18-75 years, open to both male and female participants;\n2. Normal hepatic\u002Frenal function and cardiac function;\n3. Expected survival of at least 12 weeks;\n4. Good adherence to follow-up;\n5. Presence of at least one measurable target lesion according to RECIST 1.1 criteria;\n6. Women of childbearing age (15-49 years) must undergo a pregnancy test within seven days prior to the commencement of the study and test negative; sexually active male and female participants must agree to utilize effective contraception to prevent pregnancy during the study and for three months following the final examination;\n7. Patients for whom a clinical physician recommends PET\u002FCT scans for the diagnosis and staging of tumors;\n8. Participants must fully understand and voluntarily agree to participate in the study, and must sign an informed consent form.\n\nExclusion Criteria:\n\n1. Severe abnormalities in liver and renal function and blood counts;\n2. Patients planning to conceive;\n3. Pregnant or lactating women;\n4. Individuals unable to lie flat for thirty minutes;\n5. Individuals who refuse to participate in this clinical study;\n6. Individuals suffering from claustrophobia or other psychiatric disorders;\n7. Other situations deemed unsuitable for trial participation by the researchers.",true,"ALL","18 Years","75 Years",{"count":21,"type":22},88,"ESTIMATED","INTERVENTIONAL",[25],"NA","The investigators developed a 18F labeled small molecule, 18F-TSPF, based on c-Met TKI, as a targeted molecular imaging agent for noninvasive and repeatable detecting c-Met activation status.",[28,29],"PET\u002FCT Imaging","NSCLC","RECRUITING","2025-03-28",{"date":33,"type":34},"2025-04-04","ACTUAL",{"date":36,"type":34},"2023-10-26",{"date":38,"type":22},"2025-06-28",{"name":40,"class":41},"Xilin Sun","OTHER",""]